NCT07639931尚未招募不适用
Integration and Application Demonstration of Key Diagnosis and Treatment Technologies for Severe Acute High Altitude Disease
Tibet Autonomous Region People's Hospital1 个研究点 分布在 1 个国家目标入组 3,035 人开始时间: 2026年7月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 3,035
- 试验地点
- 1
研究概览
简要总结
This study aims to establish a key technical system for the diagnosis and treatment of severe acute mountain sickness based on real-world clinical data in Xizang, develop standardized diagnosis and treatment protocols and an intelligent early warning model, validate its efficacy through multicenter studies, and innovate diagnostic and therapeutic technologies. It will achieve early identification, precise diagnosis, standardized treatment, and intelligent warning of severe acute mountain sickness, comprehensively improving its prevention, control and treatment success rate.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Meeting the diagnostic criteria for severe acute mountain sickness (including high-altitude pulmonary edema [HAPE] and high-altitude cerebral edema [HACE]).
- •Aged 18 to 75 years.
- •Rapid ascent to an altitude above 2500 m within 72 hours prior to onset.
排除标准
- •History of severe cardiopulmonary diseases.
- •Pregnant women, patients with psychiatric disorders, inability to cooperate with treatment or follow-up, and patients with an expected survival of less than 6 months.
- •Patients with malignant tumors, severe hepatic or renal insufficiency, or immune system diseases requiring immunosuppressive therapy.
研究者
Gesang Lobb
First-Class Chief Physician, Department of Cardiovascular Medicine
Tibet Autonomous Region People's Hospital
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
神经急重症患者的多维度诊断与治疗ChiCTR2300079247中央高水平医院临床科研专项
Unknown
不适用
基于简易指标的急性主动脉综合征诊断ChiCTR2600117592自选课题(自筹)
Unknown
不适用
肺炎患者潜在危重症快速识别系统的设计与应用ChiCTR1800014318自筹
尚未招募
不适用
Evaluation of an AI Based Tool for Early Diagnosis and Prediction of DiseasesCTRI/2025/10/096546Superceuticals Private Ltd1,000
尚未招募
Unknown
基于数字孪生和人工智能的危重创伤诊疗关键技术研发ChiCTR2500106923四川省科技厅200
